Medical Condition

head and neck neoplasms

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 2, Phase 3, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for head and neck neoplasms sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — head and neck neoplasms Clinical Trials

How many clinical trials are currently recruiting for head and neck neoplasms?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for head and neck neoplasms, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for head and neck neoplasms?

head and neck neoplasms research spans Phase 1 (3 trials), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a head and neck neoplasms clinical trial?

Eligibility criteria for head and neck neoplasms trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

Youssef Hashem Hafez 1 trial

University Medical Center Groningen 1 trial

Norwegian University of Science and Technology 1 trial

All India Institute of Medical Sciences, Jodhpur 1 trial

Sahlgrenska University Hospital 1 trial

Recruiting Clinical Trials

NCT07778290

Recruiting

Topical Boswellia Serrata 2% to Prevent Radiation Dermatitis in Head and Neck Cancer

Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors

University Medical Center Gron...

View Trial →

NCT04612075

Recruiting

The EMINENCE Study - PET/MR Imaging of Head Neck Cancer

Norwegian University of Scienc...

View Trial →

NCT06737822 Phase 3

Recruiting

Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers:

All India Institute of Medical...

View Trial →

NCT05432297

Recruiting

Preventive Physical Activity Intervention in Head and Neck Cancer

Sahlgrenska University Hospita...

View Trial →

NCT05106608

Recruiting

Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study

Universidad de Granada

View Trial →

NCT04075305

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Enrollment

8,000 pts

Location

United States, Austr...

EMST in Patients Undergoing CRT for HNCA

University of Wisconsin, Milwa...

View Trial →

NCT07339176 Phase 1, Phase 2

Recruiting

Intratumoral N17350 in Advanced Solid Tumors

Enrollment

275 pts

Location

United States, Austr...

The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD)

University of Manchester

View Trial →

NCT06912087 Phase 1

Recruiting

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

University of Chicago

View Trial →

NCT04429542 Phase 1

Recruiting

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Enrollment

292 pts

Location

United States, Austr...

Sponsor

Bicara Therapeutics

View Trial →

Related Conditions

carcinoma squamous cell (3) melanoma (2) head and neck cancer (2) radiodermatitis (1) msi h cancer (1) oral cancer (1) physical inactivity (1) xerostomia (1) oncology (1) breast cancer (1) prostate cancer (1) gynecologic cancer (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology